Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin–nicotinamide-induced diabetes in rats
Journal of Pharmacy and Pharmacology · 2023
DOI: 10.1093/jpp/rgad063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Swee Ching Tan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Triterpenes, Insulins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
Madecassoside (MAD) is a triterpenoid constituent of Centella asiatica (L.) Urb., an ethnomedical tropical plant, extracts of which were shown to reduce blood glucose in experimental diabetes. This study examines MAD for its anti-hyperglycaemic effects and tests the hypothesis that it reduces the blood glucose in experimentally induced diabetic rats by protecting the β-cells.
Methods
Diabetes was induced using streptozotocin (60 mg/kg, i.v.) followed by nicotinamide (210 mg/kg, intraperitoneal (i.p.)). MAD (50 mg/kg) was administered orally for 4 weeks, commencing 15 days after induction of diabetes; resveratrol (10 mg/kg) was used as a positive control. Fasting blood glucose, plasma insulin, HbA1c, liver and lipid parameters were measured, along with antioxidant enzymes and malondialdehyde as an index of lipid peroxidation; histological and immunohistochemical studies were also undertaken. Key findings MAD normalized the elevated fasting blood glucose levels. This was associated with increased plasma insulin concentrations. MAD alleviated oxidative stress by improving enzymatic antioxidants and reducing lipid peroxidation. Histopathological examination showed significant recovery of islet structural degeneration and an increased area of islets. Immunohistochemical staining showed increased insulin content in islets of MAD-treated rats.
Conclusions
The results demonstrate an antidiabetic effect of MAD associated with preservation of β-cell structure and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
- Faculty of Medicine, University of Adelaide, Adelaide, Australia.
- Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
- GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.
- Department of Pathology, School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
- Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia.
ORCID-Profile: Mayuren Candasamy
Förderung
- Fundamental Research Grant Scheme
- Ministry of Higher Education, Malaysia
Zitieren
APA
Tan, S. C., Rajendran, R., Bhattamisra, S. K., Krishnappa, P., Davamani, F., Chitra, E., Ambu, S., Furman, B., & Candasamy, M. (2023). Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin–nicotinamide-induced diabetes in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad063
Vancouver
Tan SC, Rajendran R, Bhattamisra SK, Krishnappa P, Davamani F, Chitra E, et al. Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin–nicotinamide-induced diabetes in rats. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad063
BibTeX
@article{Tan2023,
author = {Tan, Swee Ching and Rajendran, Ramkumar and Bhattamisra, Subrat Kumar and Krishnappa, Purushotham and Davamani, Fabian and Chitra, Ebenezer and Ambu, Stephen and Furman, Brian and Candasamy, Mayuren},
title = {Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin–nicotinamide-induced diabetes in rats},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
doi = {10.1093/jpp/rgad063}
}
EUVIMED